SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-010038
Filing Date
2019-05-15
Accepted
2019-05-15 15:19:27
Documents
64
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bcda20190409_10q.htm 10-Q 533850
2 EXHIBIT 31.1 ex_144386.htm EX-31.1 12322
3 EXHIBIT 31.2 ex_144387.htm EX-31.2 11500
4 EXHIBIT 32.1 ex_144388.htm EX-32.1 4662
5 EXHIBIT 32.2 ex_144389.htm EX-32.2 4627
  Complete submission text file 0001437749-19-010038.txt   3070843

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bcda-20190331.xml EX-101.INS 535755
7 XBRL TAXONOMY EXTENSION SCHEMA bcda-20190331.xsd EX-101.SCH 44700
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcda-20190331_cal.xml EX-101.CAL 33723
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20190331_def.xml EX-101.DEF 242003
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20190331_lab.xml EX-101.LAB 219816
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20190331_pre.xml EX-101.PRE 271860
Mailing Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070
Business Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

IRS No.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21419 | Film No.: 19827531
SIC: 2836 Biological Products, (No Diagnostic Substances)